Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3.

Ramya Devi, K T; Jaganathan, M K; Ganesh, M R; Dharshene, Karthick

Ramya Devi, K T; Jaganathan, M K; Ganesh, M R; Dharshene, Karthick.

Afiliação

Ramya Devi KT; Faculty of Engineering and Technology, Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India. ramyakanth3@gmail.com.
Jaganathan MK; Faculty of Engineering and Technology, Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
Ganesh MR; Department of Chemistry, College of Enginering and Technology, SRM institute of Science and Technology, Interdisciplinary Institute of Indian System of Medicine, Kattankulathur, Chennai, Tamil Nadu, 603203, India.
Dharshene K; Faculty of Engineering and Technology, Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

Med Oncol ; 41(1): 3, 2023 Nov 28.

Article em En | MEDLINE | ID: mdl-38017323

Assuntos

Antineoplásicos; Quitosana; Nanopartículas; Humanos; Espécies Reativas de Oxigênio/metabolismo; Caspase 3; Antineoplásicos/farmacologia

Palavras-chave

Breast cancer; Chitosan; Nanoparticle; Naringenin; Oxidative stress; ROS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quitosana / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Revista: Med Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google